Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Immunotherapy Industry 2016 Deep Market Research Report

  • QYR621892
  • 135 Pages
  • July 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
The United States Immunotherapy Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Immunotherapy industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Immunotherapy market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Immunotherapy industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 153 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview

1.1 Definition and Specifications of Immunotherapy

1.1.1 Definition of Immunotherapy

1.1.2 Specifications of Immunotherapy

1.2 Classification of Immunotherapy

1.3 Applications of Immunotherapy

1.4 Industry Chain Structure of Immunotherapy

1.5 Industry Overview of Immunotherapy

1.6 Industry Policy Analysis of Immunotherapy

1.7 Industry News Analysis of Immunotherapy

2 Manufacturing Cost Structure Analysis of Immunotherapy

2.1 Bill of Materials (BOM) of Immunotherapy

2.2 BOM Price Analysis of Immunotherapy

2.3 Labor Cost Analysis of Immunotherapy

2.4 Depreciation Cost Analysis of Immunotherapy

2.5 Manufacturing Cost Structure Analysis of Immunotherapy

2.6 Manufacturing Process Analysis of Immunotherapy

2.7 United States Price, Cost and Gross of Immunotherapy 2011-2016

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of United States Key Immunotherapy Manufacturers in 2015

3.3 R&D Status and Technology Source of United States Immunotherapy Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of United States Immunotherapy Key Manufacturers in 2015

4 Production Analysis of Immunotherapy by Regions, Type, and Applications

4.1 United States Production of Immunotherapy by Regions 2011-2016

4.2 United States Production of Immunotherapy by Type 2011-2016

4.3 United States Sales of Immunotherapy by Applications 2011-2016

4.4 Price Analysis of United States Immunotherapy Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Immunotherapy 2011-2016

5 Consumption Volume and Consumption Value Analysis of Immunotherapy by Regions

5.1 United States Consumption Volume of Immunotherapy by Regions 2011-2016

5.2 United States Consumption Value of Immunotherapy by Regions 2011-2016

5.3 United States Consumption Price Analysis of Immunotherapy by Regions 2011-2016

6 Analysis of Immunotherapy Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Immunotherapy 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Immunotherapy 2014-2015

6.3 Sales Overview of Immunotherapy 2011-2016

6.4 Supply, Consumption and Gap of Immunotherapy 2011-2016

6.5 Import, Export and Consumption of Immunotherapy 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Immunotherapy 2011-2016

7 Analysis of Immunotherapy Industry Key Manufacturers

7.1 Roche

7.1.1 Company Profile

7.1.2 Product Picture and Specifications

7.1.2.1 Type I

7.1.2.2 Type II

7.1.2.3 Type III

7.1.3 Capacity, Production, Price, Cost, Gross and Revenue

7.1.4 Contact Information

7.2 Merck

7.2.1 Company Profile

7.2.2 Product Picture and Specifications

7.2.2.1 Type I

7.2.2.2 Type II

7.2.2.3 Type III

7.2.3 Capacity, Production, Price, Cost, Gross and Revenue

7.2.4 Contact Information

7.3 Novartis

7.3.1 Company Profile

7.3.2 Product Picture and Specifications

7.3.2.1 Type I

7.3.2.2 Type II

7.3.2.3 Type III

7.3.3 Capacity, Production, Price, Cost, Gross and Revenue

7.3.4 Contact Information

7.4 GlaxoSmithKline (GSK)

7.4.1 Company Profile

7.4.2 Product Picture and Specifications

7.4.2.1 Type I

7.4.2.2 Type II

7.4.2.3 Type III

7.4.3 Capacity, Production, Price, Cost, Gross and Revenue

7.4.4 Contact Information

7.5 Amgen

7.5.1 Company Profile

7.5.2 Product Picture and Specifications

7.5.2.1 Type I

7.5.2.2 Type II

7.5.2.3 Type III

7.5.3 Capacity, Production, Price, Cost, Gross and Revenue

7.5.4 Contact Information

7.6 Bristol-Myers Squibb

7.6.1 Company Profile

7.6.2 Product Picture and Specifications

7.6.2.1 Type I

7.6.2.2 Type II

7.6.2.3 Type III

7.6.3 Capacity, Production, Price, Cost, Gross and Revenue

7.6.4 Contact Information

7.7 Eli Lilly and Company

7.7.1 Company Profile

7.7.2 Product Picture and Specifications

7.7.2.1 Type I

7.7.2.2 Type II

7.7.2.3 Type III

7.7.3 Capacity, Production, Price, Cost, Gross and Revenue

7.7.4 Contact Information

7.8 Celgene

7.8.1 Company Profile

7.8.2 Product Picture and Specifications

7.8.2.1 Type I

7.8.2.2 Type II

7.8.2.3 Type III

7.8.3 Capacity, Production, Price, Cost, Gross and Revenue

7.8.4 Contact Information

7.9 Seattle Genetics

7.9.1 Company Profile

7.9.2 Product Picture and Specifications

7.9.2.1 Type I

7.9.2.2 Type II

7.9.2.3 Type III

7.9.3 Capacity, Production, Price, Cost, Gross and Revenue

7.9.4 Contact Information

7.10 Spectrum Pharmaceuticals

7.10.1 Company Profile

7.10.2 Product Picture and Specifications

7.10.2.1 Type I

7.10.2.2 Type II

7.10.2.3 Type III

7.10.3 Capacity, Production, Price, Cost, Gross and Revenue

7.10.4 Contact Information

8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Immunotherapy Product Types

8.5 Market Share Analysis of Different Immunotherapy Price Levels

8.6 Gross Margin Analysis of Different Immunotherapy Applications

9 Marketing Trader or Distributor Analysis of Immunotherapy

9.1 Marketing Channels Status of Immunotherapy

9.2 Traders or Distributors of Immunotherapy with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Immunotherapy

9.4 United States Import, Export and Trade Analysis of Immunotherapy

10 Development Trend of Immunotherapy Industry 2016-2021

10.1 Capacity and Production Overview of Immunotherapy 2016-2021

10.2 Production Market Share by Product Types of Immunotherapy 2016-2021

10.3 Sales and Sales Revenue Overview of Immunotherapy 2016-2021

10.4 United States Sales of Immunotherapy by Applications 2016-2021

10.5 Import, Export and Consumption of Immunotherapy 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Immunotherapy 2016-2021

11 Industry Chain Suppliers of Immunotherapy with Contact Information

11.1 Major Raw Materials Suppliers of Immunotherapy with Contact Information

11.2 Manufacturing Equipment Suppliers of Immunotherapy with Contact Information

11.3 Major Players of Immunotherapy with Contact Information

11.4 Key Consumers of Immunotherapy with Contact Information

11.5 Supply Chain Relationship Analysis of Immunotherapy

12 New Project Investment Feasibility Analysis of Immunotherapy

12.1 New Project SWOT Analysis of Immunotherapy

12.2 New Project Investment Feasibility Analysis of Immunotherapy

13 Conclusion of the United States Immunotherapy Industry 2016 Market Research Report

List of Tables and Figures

Figure Picture of Immunotherapy

Table Product Specifications of Immunotherapy

Table Classification of Immunotherapy

Figure United States Sales Market Share of Immunotherapy by Product Types in 2015

Table Applications of Immunotherapy

Figure United States Sales Market Share of Immunotherapy by Applications in 2015

Figure Industry Chain Structure of Immunotherapy

Table United States Industry Overview of Immunotherapy

Table Industry Policy of Immunotherapy

Table Industry News List of Immunotherapy

Table Bill of Materials (BOM) of Immunotherapy

Table Bill of Materials (BOM) Price of Immunotherapy

Table Labor Cost of Immunotherapy

Table Depreciation Cost of Immunotherapy

Table Manufacturing Cost Structure Analysis of Immunotherapy in 2015

Figure Manufacturing Process Analysis of Immunotherapy

Table United States Price Analysis of Immunotherapy 2011-2016 (USD/Unit)

Table United States Cost Analysis of Immunotherapy 2011-2016 (USD/Unit)

Table United States Gross Analysis of Immunotherapy 2011-2016

Table Capacity (K Units) and Commercial Production Date of United States Immunotherapy Key Manufacturers in 2015

Table Manufacturing Plants Distribution of United States Key Immunotherapy Manufacturers in 2015

Table R&D Status and Technology Source of United States Immunotherapy Key Manufacturers in 2015

Table Raw Materials Sources Analysis of United States and United States Immunotherapy Key Manufacturers in 2015

Table United States Production of Immunotherapy by Regions 2011-2016 (K Units)

Table United States Production Market Share of Immunotherapy by Regions 2011-2016

Figure United States Production Market Share of Immunotherapy by Regions in 2014

Figure United States Production Market Share of Immunotherapy by Regions in 2015

Table United States Production of Immunotherapy by Types in 2011-2016 (K Units)

Table United States Production Market Share of Immunotherapy by Type in 2011-2016

Figure United States Production Market Share of Immunotherapy by Type in 2014

Figure United States Production Market Share of Immunotherapy by Type in 2015

Table United States Sales of Immunotherapy by Applications 2011-2016 (K Units)

Table United States Production Market Share of Immunotherapy by Applications 2011-2016

Figure United States Production Market Share of Immunotherapy by Applications in 2014

Figure United States Production Market Share of Immunotherapy by Applications in 2015

Table Price Comparison of United States Immunotherapy Key Manufacturers in 2015 (USD/Unit)

Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Immunotherapy 2011-2016

Table United States Consumption Volume of Immunotherapy by Regions 2011-2016 (K Units)

Table United States Consumption Volume Market Share of Immunotherapy by Regions 2011-2016

Figure United States Consumption Volume Market Share of Immunotherapy by Regions in 2014

Figure United States Consumption Volume Market Share of Immunotherapy by Regions in 2015

Table United States Consumption Value of Immunotherapy by Regions 2011-2016 (M USD)

Table United States Consumption Value Market Share of Immunotherapy by Regions 2011-2016

Figure United States Consumption Value Market Share of Immunotherapy by Regions in 2014

Figure United States Consumption Value Market Share of Immunotherapy by Regions in 2015

Table Consumption Price of Immunotherapy by Regions 2011-2016 (USD/Unit)

Table United States and Major Manufacturers Capacity of Immunotherapy 2011-2016 (K Units)

Table United States Capacity Market Share of Major Immunotherapy Manufacturers 2011-2016

Table United States and Major Manufacturers Production of Immunotherapy 2011-2016 (K Units)

Table United States Production Market Share of Major Immunotherapy Manufacturers 2011-2016

Table United States and Major Manufacturers Sales of Immunotherapy 2011-2016 (K Units)

Table United States Sales Market Share of Major Immunotherapy Manufacturers 2011-2016

Table United States and Major Manufacturers Sales Revenue of Immunotherapy 2011-2016 (M USD)

Table United States Sales Revenue Market Share of Major Immunotherapy Manufacturers 2011-2016

Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Immunotherapy 2011-2016

Figure United States Capacity Utilization Rate of Immunotherapy 2011-2016

Figure United States Sales Revenue (M USD) and Growth Rate of Immunotherapy 2011-2016

Figure United States Production Market Share of Major Immunotherapy Manufacturers in 2014

Figure United States Production Market Share of Major Immunotherapy Manufacturers in 2015

Figure United States Sales Market Share of Major Immunotherapy Manufacturers in 2014

Figure United States Sales Market Share of Major Immunotherapy Manufacturers in 2015

Figure United States Sales (K Units) and Growth Rate of Immunotherapy 2011-2016

Table United States Supply, Consumption and Gap of Immunotherapy 2011-2016 (K Units)

Table United States Import, Export and Consumption of Immunotherapy 2011-2016 (K Units)

Table Price of United States Immunotherapy Major Manufacturers 2011-2016 (USD/Unit)

Table Gross Margin of United States Immunotherapy Major Manufacturers 2011-2016

Table United States and Major Manufacturers Revenue of Immunotherapy 2011-2016 (M USD)

Table United States Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Immunotherapy 2011-2016

Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Immunotherapy Picture and Specifications of Roche

Table Immunotherapy Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2011-2016

Figure Immunotherapy Capacity (K Units), Production (K Units) and Growth Rate of Roche 2011-2016

Figure Immunotherapy Production (K Units) and United States Market Share of Roche 2011-2016

Table Roche Immunotherapy SWOT Analysis

Table Merck Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Immunotherapy Picture and Specifications of Merck

Table Immunotherapy Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2011-2016

Figure Immunotherapy Capacity (K Units), Production (K Units) and Growth Rate of Merck 2011-2016

Figure Immunotherapy Production (K Units) and United States Market Share of Merck 2011-2016

Table Merck Immunotherapy SWOT Analysis

Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Immunotherapy Picture and Specifications of Novartis

Table Immunotherapy Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2011-2016

Figure Immunotherapy Capacity (K Units), Production (K Units) and Growth Rate of Novartis 2011-2016

Figure Immunotherapy Production (K Units) and United States Market Share of Novartis 2011-2016

Table Novartis Immunotherapy SWOT Analysis

Table GlaxoSmithKline (GSK) Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Immunotherapy Picture and Specifications of GlaxoSmithKline (GSK)

Table Immunotherapy Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of GlaxoSmithKline (GSK) 2011-2016

Figure Immunotherapy Capacity (K Units), Production (K Units) and Growth Rate of GlaxoSmithKline (GSK) 2011-2016

Figure Immunotherapy Production (K Units) and United States Market Share of GlaxoSmithKline (GSK) 2011-2016

Table GlaxoSmithKline (GSK) Immunotherapy SWOT Analysis

Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Immunotherapy Picture and Specifications of Amgen

Table Immunotherapy Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2011-2016

Figure Immunotherapy Capacity (K Units), Production (K Units) and Growth Rate of Amgen 2011-2016

Figure Immunotherapy Production (K Units) and United States Market Share of Amgen 2011-2016

Table Amgen Immunotherapy SWOT Analysis

Table Bristol-Myers Squibb Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Immunotherapy Picture and Specifications of Bristol-Myers Squibb

Table Immunotherapy Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2011-2016

Figure Immunotherapy Capacity (K Units), Production (K Units) and Growth Rate of Bristol-Myers Squibb 2011-2016

Figure Immunotherapy Production (K Units) and United States Market Share of Bristol-Myers Squibb 2011-2016

Table Bristol-Myers Squibb Immunotherapy SWOT Analysis

Table Eli Lilly and Company Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Immunotherapy Picture and Specifications of Eli Lilly and Company

Table Immunotherapy Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly and Company 2011-2016

Figure Immunotherapy Capacity (K Units), Production (K Units) and Growth Rate of Eli Lilly and Company 2011-2016

Figure Immunotherapy Production (K Units) and United States Market Share of Eli Lilly and Company 2011-2016

Table Eli Lilly and Company Immunotherapy SWOT Analysis

Table Celgene Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Immunotherapy Picture and Specifications of Celgene

Table Immunotherapy Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Celgene 2011-2016

Figure Immunotherapy Capacity (K Units), Production (K Units) and Growth Rate of Celgene 2011-2016

Figure Immunotherapy Production (K Units) and United States Market Share of Celgene 2011-2016

Table Celgene Immunotherapy SWOT Analysis

Table Seattle Genetics Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Immunotherapy Picture and Specifications of Seattle Genetics

Table Immunotherapy Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Seattle Genetics 2011-2016

Figure Immunotherapy Capacity (K Units), Production (K Units) and Growth Rate of Seattle Genetics 2011-2016

Figure Immunotherapy Production (K Units) and United States Market Share of Seattle Genetics 2011-2016

Table Seattle Genetics Immunotherapy SWOT Analysis

Table Spectrum Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Immunotherapy Picture and Specifications of Spectrum Pharmaceuticals

Table Immunotherapy Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Spectrum Pharmaceuticals 2011-2016

Figure Immunotherapy Capacity (K Units), Production (K Units) and Growth Rate of Spectrum Pharmaceuticals 2011-2016

Figure Immunotherapy Production (K Units) and United States Market Share of Spectrum Pharmaceuticals 2011-2016

Table Spectrum Pharmaceuticals Immunotherapy SWOT Analysis

Table Immunotherapy Price by Regions 2011-2016

Table Immunotherapy Price by Product Types 2011-2016

Table Immunotherapy Price by Companies 2011-2016

Table Immunotherapy Gross Margin by Companies 2011-2016

Table Price Comparison of Immunotherapy by Regions 2011-2016 (USD/Unit)

Table Price of Different Immunotherapy Product Types (USD/Unit)

Table Market Share of Different Immunotherapy Price Level

Table Gross Margin of Different Immunotherapy Applications

Table Marketing Channels Status of Immunotherapy

Table Traders or Distributors of Immunotherapy with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Immunotherapy (USD/Unit) in 2015

Table United States Import, Export, and Trade of Immunotherapy (K Units)

Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Immunotherapy 2016-2021

Figure United States Capacity Utilization Rate of Immunotherapy 2016-2021

Table United States Immunotherapy Production by Type 2016-2021 (K Units)

Table United States Immunotherapy Production Market Share by Type 2016-2021

Figure United States Production Market Share of Immunotherapy by Type in 2021

Figure United States Sales (K Units) and Growth Rate of Immunotherapy 2016-2021

Figure United States Sales Revenue (Million USD) and Growth Rate of Immunotherapy 2016-2021

Figure United States Sales of Immunotherapy by Applications 2016-2021 (K Units)

Table United States Production Market Share of Immunotherapy by Applications 2016-2021

Figure United States Production Market Share of Immunotherapy by Applications in 2021

Table United States Production, Import, Export and Consumption of Immunotherapy 2016-2021 (K Units)

Table United States Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Immunotherapy 2016-2021

Table Major Raw Materials Suppliers of Immunotherapy with Contact Information

Table Manufacturing Equipment Suppliers of Immunotherapy with Contact Information

Table Major Players of Immunotherapy with Contact Information

Table Key Consumers of Immunotherapy with Contact Information

Table Supply Chain Relationship Analysis of Immunotherapy

Table New Project SWOT Analysis of Immunotherapy

Table New Project Investment Feasibility Analysis of Immunotherapy

Table Part of Interviewees Record List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370